Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin and Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme
NCT00028678Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jul 2002
- Primary completion
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of dalteparin in glioblastoma multiforme (GBM), sponsored by Eastern Cooperative Oncology Group. Started Jul 2002; status: completed.
02
Drugs
dalteparin
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00028678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028678.